Paragon 28 — FY2023 Earnings Presentation
10 slides from Paragon 28's earnings presentation, Feb 29, 2024
Slide 1: 4Q and Full Year 2023 Update
4Q and Full Year 2023 Update February 29, 2024 Exhibit 99.2
Slide 2: Forward Looking Statements
Forward Looking Statements Except for the historical information contained herein, the matters set forth in this presentation are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to: Para
Slide 3: Non-GAAP Financial Measures
Non-GAAP Financial Measures In addition to our results and measures of performance determined in accordance with U.S. GAAP presented in this press release, we believe that certain non-GAAP financial measures are useful in evaluating and comparing our financial and operational performance over multip
Slide 4: Full Year 2023 Update – Table of Contents
4Q and Full Year 2023 Update – Table of Contents 4Q and FY 2023 Highlights 5 4Q and FY 2023 Net Revenue 6 FY 2024 Net Revenue Guidance 7 2020 – 2023 Operating Cash Flow Trends and Implications for 2024 8 The Global Foot & Ankle Market 9 Continued Strong Product Launch Cadence & Pipeline 10
Slide 5: FY 2023 Highlights
4Q and FY 2023 Highlights Above Market Revenue Growth Continued in 4Q 2023; Providing 2024 Net Revenue Guidance Net Revenue Performance & Guidance Key Operational and Financial Details Strategic Highlights Global Net Revenue (YoY Growth): 4Q: $60.6M (+17.6% reported; +17.3% CC) | FY 2023: $216.4M (+
Slide 6: 4Q and FY 2023 Net Revenue
4Q and FY 2023 Net Revenue 4Q Net Revenue Sustained performance through 4Q 2023 with significant momentum across key leading indicators to drive future growth FY 2023 Net Revenue Consolidated Growth: + 17.6% Reported + 17.3% Constant Currency Int’l: + 43.1% Rep. + 40.7% CC U.S.: + 14.1% Rep. Consoli
Slide 7: FY 2024 Net Revenue Guidance
FY 2024 Net Revenue Guidance 2024 Quarterly Growth Rate Expectations Normalized seasonality to continue 1Q 2024 is expected to be the lowest quarterly year-over-year growth percentage as 1Q 2023 was the highest growth quarter of 2024 (27% constant currency) and 1Q 2024 has one less billing day We ex
Slide 8: 2020–2023 Operating Cash Flow Trends and Implications for 2024
Solid foundation of investments in place to drive P28 towards future profitability and positive cash flow. 2022 – 2023 Cumulative Operating Cash Use Normalized operating cash use of $23.0M from 1/1/22 through 12/31/23. Significant improvements in operating cash flow expected for 2024 and beyond. Key
Slide 9: The Global Foot & Ankle Market
The Global Foot & Ankle Market Global Foot & Ankle Market(1) Market Sub-segments(1) Estimated 2023 Global Market(2) CAGR: 7.1% Source: iData Research and Company estimates. Source: Company filings, SmartTrak, and management estimates. Fast Growing Market with Several Key Differentiators Paragon 28 M
Slide 10: Continued Strong Product Launch Cadence & Pipeline
Continued Strong Product Launch Cadence & Pipeline 2 Product Launches in Q4 2023 and 6 Product Launches in 2024 YTD(1) Robust Pipeline 25+ Active Projects in Development Balanced Across Portfolio 5-10 Annual Launches Expected In Next Three Years 1st Smart28 Module Planned for Mid-2024(3) January 5,